Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver

The human drug metabolizing cytochrome P450 (CYP) 1A2, is one of the major P450 isoforms contributing by about 5–20% to the hepatic P450 pool and catalyzing oxidative biotransformation of up to 10% of clinically relevant drugs including clozapine and caffeine. CYP1A2 activity is interindividually hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Kathrin, Winter, Stefan, Turpeinen, Miia, Schwab, Matthias, Zanger, Ulrich M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2010
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171976/
https://www.ncbi.nlm.nih.gov/pubmed/21918647
http://dx.doi.org/10.3389/fphar.2010.00129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171976/
https://www.ncbi.nlm.nih.gov/pubmed/21918647
http://dx.doi.org/10.3389/fphar.2010.00129

Ejemplares similares